ArticleUrologie (Heidelberg, Germany)2026
[Erectile dysfunction-It is time to act! : Practical tips and current guideline recommendations for diagnostics and treatment of a still underestimated disease].
Article in Urologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The main risk factors for erectile dysfunction (ED) are age, smoking, metabolic syndrome, cardiovascular diseases, diabetes and status following pelvic surgery. The diagnostics include a (psychosexual) medical history, a physical examination, basic laboratory diagnostics with fasting glucose, lipid profile and morning testosterone level. Extended hormone diagnostics follow if there is a corresponding suspicion. The same applies to the special functional tests, such as measurement of nocturnal erections or intracavernous injection tests with Doppler sonography. The guideline-based staging schedule of conservative treatment options includes risk factor and lifestyle modifications, phosphodiesterase 5 inhibitors (PDE5I), topical/intraurethral vasoactive substances and penile vacuum therapy. The surgical treatment options include revascularization in cases of posttraumatic ED and implantation of penile prosthetics as the gold standard.
Indexed as
Identifiers
41504781What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.